Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report) fell 1% on Thursday. The company traded as low as $3.3540 and last traded at $3.3565. 8,725 shares were traded during trading, a decline of 35% from the average session volume of 13,521 shares. The stock had previously closed at $3.39.
Medexus Pharmaceuticals Trading Up 2.1%
The stock’s 50-day simple moving average is $3.62 and its 200 day simple moving average is $3.21.
Medexus Pharmaceuticals Company Profile
Medexus Pharmaceuticals Inc is a specialty pharmaceutical company focused on acquiring, commercializing and marketing prescription and nonprescription healthcare products in North America. The company works with products that address specialized and underserved therapeutic areas, with operations and commercial activities primarily in the United States and Canada.
Medexus’ portfolio includes IXINITY, a recombinant factor IX therapy used for the treatment and prevention of bleeding in people with hemophilia B.
Further Reading
- Five stocks we like better than Medexus Pharmaceuticals
- Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
- Delta Air Lines Faces a Fuel Crisis—But There’s a Silver Lining
- Is Synopsys Back from the Dead? EDA Leader Inks Deals With Amazon and OpenAI
- MarketBeat Week in Review – 10/05 – 10/09
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
